Managers / Q2 2021 · view latest →
Opti Capital Management, LP
CIK 0001738654 · 120 WEST 45TH STREET, NEW YORK, NY, 10036 · 2124302184
Summary
Opti Capital Management, LP reported $933M in U.S.-listed holdings across 35 positions for Q2 2021.
Its largest position, Natera, represents 10.7% of the portfolio.
Compared with Q1 2021, the fund opened 21 new positions and exited 21.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- US DOMESTIC · 99.4% · $927M
- GLOBAL · 0.5% · $5M
- Common Stock · 0.1% · $488,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| NATERA INC | NEW | +32.90M | 32.90M | +$100M | $100M |
| DICKS SPORTING GOODS INC | NEW | +24.37M | 24.37M | +$72M | $72M |
| CONMED CORP | NEW | +44.06M | 44.06M | +$71M | $71M |
| CREE INC | NEW | +26.50M | 26.50M | +$58M | $58M |
| SLACK TECHNOLOGIES INC | NEW | +31.32M | 31.32M | +$47M | $47M |
| SAILPOINT TECHNOLOGIES HLDGS | NEW | +23.98M | 23.98M | +$45M | $45M |
| FORTIVE CORP | NEW | +31.93M | 31.93M | +$32M | $32M |
| COHERUS BIOSCIENCES INC | NEW | +29.15M | 29.15M | +$30M | $30M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | NATERA INC | NOTE 2.250% 5/0 | 10.71% | $100M | 32.90M |
| 2 | DICKS SPORTING GOODS INC | NOTE 3.250% 4/1 | 7.75% | $72M | 24.37M |
| 3 | CONMED CORP | NOTE 2.625% 2/0 | 7.64% | $71M | 44.06M |
| 4 | NEW RELIC INC | NOTE 0.500% 5/0 | 7.16% | $67M | 66.73M |
| 5 | CREE INC | NOTE 1.750% 5/0 | 6.17% | $58M | 26.50M |
| 6 | SLACK TECHNOLOGIES INC | NOTE 0.500% 4/1 | 5.07% | $47M | 31.32M |
| 7 | SAILPOINT TECHNOLOGIES HLDGS | NOTE 0.125% 9/1 | 4.82% | $45M | 23.98M |
| 8 | FIREEYE INC | NOTE 1.625% 6/0 | 4.03% | $38M | 37.75M |
| 9 | SUPERNUS PHARMACEUTICALS INC | NOTE 0.625% 4/0 | 3.97% | $37M | 37.35M |
| 10 | IONIS PHARMACEUTICALS INC | NOTE 0.125%12/1 | 3.65% | $34M | 36.59M |
| 11 | FORTIVE CORP | NOTE 0.875% 2/1 | 3.44% | $32M | 31.93M |
| 12 | COHERUS BIOSCIENCES INC | NOTE 1.500% 4/1 | 3.21% | $30M | 29.15M |
| 13 | BIOMARIN PHARMACEUTICAL INC | NOTE 0.599% 8/0 | 2.96% | $28M | 26.46M |
| 14 | INSIGHT ENTERPRISES INC | NOTE 0.750% 2/1 | 2.70% | $25M | 16.47M |
| 15 | KBR INC | NOTE 2.500%11/0 | 2.69% | $25M | 16.00M |
| 16 | NUVASIVE INC | NOTE 1.000% 6/0 | 2.51% | $23M | 22.41M |
| 17 | BURLINGTON STORES INC | NOTE 2.250% 4/1 | 2.47% | $23M | 14.50M |
| 18 | VONAGE HLDGS CORP | NOTE 1.750% 6/0 | 2.18% | $20M | 18.07M |
| 19 | RETROPHIN INC | NOTE 2.500% 9/1 | 2.07% | $19M | 22.58M |
| 20 | OMEROS CORP | NOTE 6.250%11/1 · NOTE 5.250% 2/1 | 2.06% | $19M | 17.20M |
| 21 | MODEL N INC | NOTE 2.625% 6/0 | 1.71% | $16M | 12.50M |
| 22 | KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 1.61% | $15M | 15.00M |
| 23 | PEGASYSTEMS INC | NOTE 0.750% 3/0 | 1.48% | $14M | 11.50M |
| 24 | FLEXION THERAPEUTICS INC | NOTE 3.375% 5/0 | 1.28% | $12M | 13.16M |
| 25 | PTC THERAPEUTICS INC | NOTE 3.000% 8/1 | 0.94% | $9M | 8.00M |
| 26 | OPKO HEALTH INC | NOTE 4.500% 2/1 | 0.86% | $8M | 6.20M |
| 27 | ON SEMICONDUCTOR CORP | NOTE 1.625%10/1 | 0.82% | $8M | 4.00M |
| 28 | WAYFAIR INC | NOTE 1.125%11/0 | 0.74% | $7M | 2.50M |
| 29 | LIGAND PHARMACEUTICALS INC | NOTE 0.750% 5/1 | 0.72% | $7M | 6.72M |
| 30 | NATIONAL VISION HLDGS INC | NOTE 2.500% 5/1 | 0.71% | $7M | 3.75M |
| 31 | IRONWOOD PHARMACEUTICALS INC | NOTE 0.750% 6/1 | 0.67% | $6M | 5.30M |
| 32 | LUMINEX CORP DEL | NOTE 3.000% 5/1 | 0.62% | $6M | 5.81M |
| 33 | EVOLENT HEALTH INC | NOTE 1.500%10/1 | 0.52% | $5M | 5.00M |
| 34 | PPURE STORAGE INC | CL A | 0.05% | $488,000 | 25.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.4B | 36 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.4B | 43 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.6B | 44 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.8B | 46 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.6B | 53 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $2.2B | 66 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.7B | 55 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | Under review | 56 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | Under review | 48 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | Under review | 50 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | Under review | 56 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.2B | 49 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.2B | 53 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.2B | 63 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.1B | 57 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.0B | 43 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.2B | 42 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.3B | 37 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.1B | 35 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $933M | 35 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $819M | 35 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $897M | 34 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $817M | 32 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $585M | 31 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $488M | 31 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $665M | 24 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $578M | 29 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $608M | 30 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $374M | 23 | May 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $210M | 25 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.